Jordan Zwick
Fortune : 704 129 $ au 30/06/2026
Fortune : 704 129 $ au 30/06/2026
Mr. Jordan Zwick is a Venture Partner at ARCH Venture Partners LLC, an Independent Director at Palisade Bio, Inc. and an Independent Director at Theratechnologies, Inc. He is on the Board of Directors at Palisade Bio, Inc. and Theratechnologies, Inc.
Mr. Zwick was previously employed as a SVP-Corporate Business Development by Amarin Corp.
Plc, a Head-Strategy by Salix Pharmaceuticals Ltd., a Trading Associate by Raymond James & Associates, Inc., and a Chief Strategy Officer by InflaRx NV.
He received his undergraduate degree from Florida Atlantic University, a graduate degree from Florida Atlantic University and an MBA from the University of San Francisco.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PALISADE BIO, INC. 0,2 % | 10/06/2026 | 336 904 ( 0,2 % ) | 704 129 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| THERATECHNOLOGIES INC. | Directeur/Membre du Conseil | 21/03/2024 |
| PALISADE BIO, INC. | Directeur/Membre du Conseil | 10/06/2026 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| AMARIN CORPORATION PLC | Corporate Officer/Principal | 01/01/2023 |
| INFLARX N.V. | Corporate Officer/Principal | 29/06/2022 |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 01/01/2020 |
Raymond James & Associates, Inc.
Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2009 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops prescription drugs | Health Technology |
Raymond James & Associates, Inc.
Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Theratechnologies, Inc.
Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Florida Atlantic University
Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InflaRx NV
InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national